Vivien Bramwell

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

Charles D. Blanke, Cathryn Rankin, George D. Demetri et al. · Journal of Clinical Oncology · 2008 · 1.1K citations

Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group

Michael C. Heinrich, Kouros Owzar, Christopher L. Corless et al. · Journal of Clinical Oncology · 2008 · 649 citations · Full text

Soft tissue sarcomas of adults: state of the translational science.

Ernest C. Borden, Laurence H. Baker, Robert S. Bell et al. · PubMed · 2003 · 616 citations

Single Gene Family, Imatinib Mesylate, Gastrointestinal Oncology +13

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial

Penella J. Woll, Peter Reichardt, Axel Le Cesne et al. · The Lancet Oncology · 2012 · 572 citations

Surgical Oncology, Soft-tissue Sarcoma, Medicine +8

<i>HER2</i> and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

Kathleen I. Pritchard, Lois E. Shepherd, Frances P. O’Malley et al. · New England Journal of Medicine · 2006 · 508 citations · Full text